Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Pittenger & Anderson advocates staying fully invested across equity cycles, framing heavy AI infrastructure buildouts and secular corporate innovation as durable long-term drivers despite power and financing constraints.
Full Quick Take
Pittenger & Anderson advocates staying fully invested across equity cycles, framing heavy AI infrastructure buildouts and secular corporate innovation as durable long-term drivers despite power and financing constraints.
Rowan Street maintains an ultra-concentrated portfolio of quality compounders led by Meta Platforms, while fully divesting The Trade Desk after deteriorating competitive moats and governance broke the core investment thesis.
Full Quick Take
Rowan Street maintains an ultra-concentrated portfolio of quality compounders led by Meta Platforms, while fully divesting The Trade Desk after deteriorating competitive moats and governance broke the core investment thesis.
Nixon Capital suffered losses through Q3 2026 driven by a 23% average drop across four of its top five holdings, prompting a total exit from PayPal after its thesis broke down.
Full Quick Take
Nixon Capital suffered losses through Q3 2026 driven by a 23% average drop across four of its top five holdings, prompting a total exit from PayPal after its thesis broke down.
Latitude Global Fund delivered modest gains of a few percent net year-to-date in 2026, as strong fundamental earnings momentum across defensive holdings was overshadowed by AI market narrowness, while maintaining an active stance against fragile, extractive franchises.
Full Quick Take
Latitude Global Fund delivered modest gains of a few percent net year-to-date in 2026, as strong fundamental earnings momentum across defensive holdings was overshadowed by AI market narrowness, while maintaining an active stance against fragile, extractive franchises.
ClearBridge Growth Strategy outperformed its benchmark in Q3 2026 through superior stock selection in software, healthcare, and industrials, utilizing market volatility to strategically build positions in critical AI networking and connectivity infrastructure.
Full Quick Take
ClearBridge Growth Strategy outperformed its benchmark in Q3 2026 through superior stock selection in software, healthcare, and industrials, utilizing market volatility to strategically build positions in critical AI networking and connectivity infrastructure.
Lagging its mid-cap value benchmark amid capital concentration in artificial intelligence equities, while core portfolio holdings accelerated accretive share buybacks at steep valuation discounts.
Full Quick Take
Lagging its mid-cap value benchmark amid capital concentration in artificial intelligence equities, while core portfolio holdings accelerated accretive share buybacks at steep valuation discounts.
Management is maintaining a measured AI footprint while reallocating capital into overlooked, durable cash generators across financials, industrials, communication services, and energy infrastructure.
Full Quick Take
Management is maintaining a measured AI footprint while reallocating capital into overlooked, durable cash generators across financials, industrials, communication services, and energy infrastructure.
The manager combines selective long compounders and tactical event-driven trades with rigorous downside limits, avoiding emotional over-commitment to deteriorating positions.
Full Quick Take
The manager combines selective long compounders and tactical event-driven trades with rigorous downside limits, avoiding emotional over-commitment to deteriorating positions.
Rising interest rates and late-quarter rotations into speculative high-beta assets disproportionately weigh on stable compounders, reinforcing high-conviction exposure to durable defense technology and industrial leaders.
Full Quick Take
Rising interest rates and late-quarter rotations into speculative high-beta assets disproportionately weigh on stable compounders, reinforcing high-conviction exposure to durable defense technology and industrial leaders.
Horizon Kinetics maintained high-conviction exposure to land assets, regulated exchanges, and Bitcoin in Q2 2026, while trimming precious metal royalty leaders trading near 2x NAV and warning against deteriorating AI hyperscaler economics.
Full Quick Take
Horizon Kinetics maintained high-conviction exposure to land assets, regulated exchanges, and Bitcoin in Q2 2026, while trimming precious metal royalty leaders trading near 2x NAV and warning against deteriorating AI hyperscaler economics.
In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories.
Full Quick Take
In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories.
Underperforming the S&P 500, but remains firmly committed to a high-concentration, low-turnover compounding strategy focused on exceptional businesses like Meta, Tesla, and Shopify.
Full Quick Take
Underperforming the S&P 500, but remains firmly committed to a high-concentration, low-turnover compounding strategy focused on exceptional businesses like Meta, Tesla, and Shopify.
Crawford Investment Counsel advocates for a disciplined, long-term approach focused on high-quality, dividend-paying stocks to navigate a lopsided U.S. economy.
Full Quick Take
Crawford Investment Counsel advocates for a disciplined, long-term approach focused on high-quality, dividend-paying stocks to navigate a lopsided U.S. economy.
Despite a tough Q3 underperforming a soaring benchmark due to a historic rotation away from high-quality compounders and unwarranted AI fears, Baron Growth Fund remains highly constructive, utilizing the downturn to concentrate its high-conviction, long-term holdings.
Full Quick Take
Despite a tough Q3 underperforming a soaring benchmark due to a historic rotation away from high-quality compounders and unwarranted AI fears, Baron Growth Fund remains highly constructive, utilizing the downturn to concentrate its high-conviction, long-term holdings.
Airlie Small Companies Fund remains focused on long-term quality compounders over market timing, highlighting a significant portfolio upweight in Sigma Healthcare (merged with Chemist Warehouse) and expressing confidence in the mispriced small-cap universe.
Full Quick Take
Airlie Small Companies Fund remains focused on long-term quality compounders over market timing, highlighting a significant portfolio upweight in Sigma Healthcare (merged with Chemist Warehouse) and expressing confidence in the mispriced small-cap universe.
Akre Focus Fund underperformed the S&P 500 this quarter (6.46% vs 10.94%) but remains committed to high-quality compounding businesses over cheap 'value' bounces, raising its cash position to 8.1% and preparing to transition into an ETF structure.
Full Quick Take
Akre Focus Fund underperformed the S&P 500 this quarter (6.46% vs 10.94%) but remains committed to high-quality compounding businesses over cheap 'value' bounces, raising its cash position to 8.1% and preparing to transition into an ETF structure.
Outperforming its benchmark's 12.3%. The fund continues to focus on long-term compounding by pruning underperforming positions and concentrating capital into high-conviction compounders.
Full Quick Take
Outperforming its benchmark's 12.3%. The fund continues to focus on long-term compounding by pruning underperforming positions and concentrating capital into high-conviction compounders.
The manager emphasizes a long-term compounding mindset, reviews historical exits to validate his investment process, and remains highly constructive on portfolio earnings growth.
Full Quick Take
The manager emphasizes a long-term compounding mindset, reviews historical exits to validate his investment process, and remains highly constructive on portfolio earnings growth.
Zeno Equity Partners rejects benchmark-chasing and traditional risk metrics, choosing instead to focus on a concentrated portfolio of resilient, high-quality compounders built to survive over an infinite horizon.
Full Quick Take
Zeno Equity Partners rejects benchmark-chasing and traditional risk metrics, choosing instead to focus on a concentrated portfolio of resilient, high-quality compounders built to survive over an infinite horizon.
Manole Capital targets high-quality, growth-oriented companies utilizing technology to improve established processes, with a heavy focus on payment sectors and financial exchanges.
Full Quick Take
Manole Capital targets high-quality, growth-oriented companies utilizing technology to improve established processes, with a heavy focus on payment sectors and financial exchanges.
Nixon Capital marks its 15th anniversary by reaffirming its commitment to a long-term, value-oriented public equity strategy, contrasting younger investors' preference for private markets with the proven power of long-term compounding.
Full Quick Take
Nixon Capital marks its 15th anniversary by reaffirming its commitment to a long-term, value-oriented public equity strategy, contrasting younger investors' preference for private markets with the proven power of long-term compounding.
Rowan Street Capital seeks to build long-term wealth by holding a concentrated portfolio of exceptional compounder companies led by strong owner-operators.
Full Quick Take
Rowan Street Capital seeks to build long-term wealth by holding a concentrated portfolio of exceptional compounder companies led by strong owner-operators.
Portfolio companies announced 99 transactions while maintaining strong cash generation and low debt levels. The fund capitalizes on Sweden's decentralized management legacy and sees significant European expansion opportunities for Nordic compounders in the vast SME market.
Full Quick Take
Portfolio companies announced 99 transactions while maintaining strong cash generation and low debt levels. The fund capitalizes on Sweden's decentralized management legacy and sees significant European expansion opportunities for Nordic compounders in the vast SME market.
Aquamarine Fund rebounded 18.7% in 2023 after a difficult 2022, but continues lagging the S&P 500 for six straight years due to avoiding mega-cap tech concentration.
Full Quick Take
Aquamarine Fund rebounded 18.7% in 2023 after a difficult 2022, but continues lagging the S&P 500 for six straight years due to avoiding mega-cap tech concentration.